AI-supported memory training for older adults with mild cognitive impairment
Tests an AI-supported thinking skills program in older adults with mild cognitive impairment.
Key facts
- Who runs it
- Kaiser Permanente
- Where
- Pasadena, United StatesSee the site
- Trial code
- Registry title
- AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment
- Status
- Enrolling by invitation
- People taking part
- 130 people, planned
- Started
- 16 Mar 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- AI-Supported Cognitive Rehabilitation
- Record updated
- 20 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 65 or older with mild cognitive impairment (MCI), meaning mild problems with memory or thinking. Participants come from an existing Kaiser Permanente Southern California research study.
- Age
- 65 years or older
- Sex
- All sexes
- Disease stage
- Diagnosis of mild cognitive impairment (MCI), with a MoCA-BLIND adjusted score of 13-18 (a short test of memory and thinking).
- Earlier treatment
- People currently getting ongoing behavioral health treatment or psychotherapy from a Kaiser Permanente clinician cannot join.
Main reasons for not taking part
- Currently getting ongoing behavioral health treatment or psychotherapy from a Kaiser Permanente clinician
- Bipolar disorder, schizophrenia spectrum disorder, or another serious mental illness that would get in the way of taking part
- Serious communication problems that would prevent conversation or video/phone sessions
- Not fluent enough in English for the study tests and sessions
- No access to, or unable to use, a computer or mobile device with internet
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age 65 years or older
- Diagnosis of mild cognitive impairment (MCI)
- Montreal Cognitive Assessment (MoCA)-BLIND adjusted score (13-18)
- Able to provide informed consent
- English fluency sufficient to complete study assessments and participate in intervention sessions
- Access to and ability to use a computer or mobile device with internet connectivity
Who cannot take part
- Diagnosis of bipolar disorder, schizophrenia spectrum disorder, or other serious mental illness that would interfere with participation
- Significant communication impairment that would prevent participation in conversational or telehealth sessions
- Current receipt of ongoing behavioral health treatment or psychotherapy from a Kaiser Permanente clinician
Where in United States
- Kaiser Permanente Southern CaliforniaPasadena, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Mild cognitive impairment (MCI) is associated with increased risk of progression to dementia, highlighting the need for accessible interventions to support cognitive health.
Read full original descriptionShow less
This randomized controlled trial will evaluate the safety and efficacy of a 12-month artificial intelligence (AI)-supported cognitive rehabilitation program for older adults with MCI. Participants will be recruited from an existing research study conducted within Kaiser Permanente Southern California and randomized 1:1 to either (1) AI-supported cognitive rehabilitation or (2) usual care alone.
The intervention combines clinician-delivered telehealth cognitive rehabilitation sessions with daily AI-guided cognitive exercises and education. The primary outcome is change in global cognition at 6 months measured by the Montreal Cognitive Assessment (MoCA)-BLIND. Secondary outcomes at 6 and 12 months include additional measures of cognition, subjective memory, goal attainment, mood, and loneliness. Exploratory outcomes include engagement with the AI intervention and health-related behavioral outcomes derived from electronic health record data.
Participant safety will be monitored throughout the study through adverse event tracking, review of AI interactions for safety concerns, and predefined procedures for responding to psychological or clinical risk.
This study will determine whether integrating AI-guided cognitive exercises with clinician-delivered rehabilitation improves cognitive and related outcomes in older adults with MCI compared to usual care.
The 2 groups in the trial
- Usual CareNo study treatment, for comparison
Participants will continue to receive usual health care and services available through their Kaiser Permanente health plan and will complete study assessments at 6 and 12 months.
- AI-Supported Cognitive RehabilitationTreatment being tested
Participants will receive a 12-month cognitive rehabilitation program that integrates clinician-delivered telehealth sessions with daily artificial intelligence (AI)-guided cognitive exercises.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluating the Efficacy of AI-Augmented Cognitive Rehabilitation in Mild Cognitive Impairment
- Plain-language title
- AI-supported memory training for older adults with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 20 March 2026